Open AccessTrial of Psilocybin versus Escitalopram for Depression
Author(s) -
Robin CarhartHarris,
Bruna Giribaldi,
Rosalind Watts,
Michelle Baker-Jones,
Ashleigh Murphy-Beiner,
Roberta Murphy,
Jonny Martell,
Allan Blemings,
David Erritzøe,
David Nutt
Publication year - 2021
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa2032994
Subject(s) - psilocybin , escitalopram , depression (economics) , psychology , psychiatry , hallucinogen , medicine , anxiety , antidepressant , macroeconomics , economics
Psilocybin may have antidepressant properties, but direct comparisons between psilocybin and established treatments for depression are lacking.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom